日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Fecal carbohydrate-degrading bacteria are associated with reduced incidence of lower gastrointestinal GVHD

粪便中碳水化合物降解菌与下消化道移植物抗宿主病(GVHD)发生率降低相关。

Fan, Christopher; Hayase, Tomo; Chang, Chia-Chi; Glover, Israel K; Flores, Ivonne I; McDaniel, Lauren K; Ortega, Miriam R; Sanchez, Christopher A; El-Himri, Rawan K; Brown, Alexandria N; Karmouch, Jennifer L; Jamal, Mohamed A; Ahmed, Saira S; Halsey, Taylor M; Jin, Yimei; Tsai, Wen-Bin; Prasad, Rishika; Enkhbayar, Altai; Mohammed, Aqsa; Schmiester, Maren; Damania, Ashish; Ajami, Nadim J; Wargo, Jennifer A; Peterson, Christine B; Rondon, Gabriela; Al-Juhaishi, Taha; Alousi, Amin M; Molldrem, Jeffrey J; Champlin, Richard E; Shpall, Elizabeth J; Martens, Eric; Arias, Cesar A; Jenq, Robert R; Hayase, Eiko

High dietary fiber is associated with improved outcomes in patients with melanoma and sarcoma treated with immunotherapy regardless of gut microbiome dysbiosis and social vulnerability

高膳食纤维与接受免疫疗法治疗的黑色素瘤和肉瘤患者的预后改善相关,且不受肠道菌群失调和社会脆弱性的影响。

Fields, Brittany C; Traweek, Raymond S; Jiang, Kai; Witt, Russell G; Damania, Ashish; Chiang, Yi-Ju; Ajami, Nadim; Nassif-Haddad, Elise; Keung, Emily Z; Chelvanambi, Manoj; Zhang, Xiaotao; Peterson, Christine B; Wargo, Jennifer A; Daniel, Carrie R; Roland, Christina L; Holder, Ashley M

International Survey on Evidence for Index Lymph Node Surgery After Neoadjuvant Systemic Therapy for Stage III Melanoma

关于新辅助全身治疗后III期黑色素瘤患者行索引淋巴结手术的证据的国际调查

Novis, Elan; Rautalin, Mervi; Amaria, Rodabe N; Ascierto, Paolo A; Blank, Christian U; Faries, Mark B; Grunhagen, Dirk J; Gyorki, David E; Hayes, Andrew J; Kuijpers, Anke M J; Long, Georgina V; Mammen, Joshua M V; Menzies, Alexander M; Ross, Merrick I; Rutkowski, Piotr; Tawbi, Hussein A; Tetzlaff, Michael T; Zager, Jonathan S; Wargo, Jennifer A; Hieken, Tina J; van Akkooi, Alexander C J

Effects of Vemurafenib ± Cobimetinib on Intratumoral and Host Immunity in Patients With BRAFV600 Mutant Melanoma: Implications for Combination With Immunotherapy

维莫非尼±考比替尼对BRAFV600突变型黑色素瘤患者肿瘤内免疫和宿主免疫的影响:与免疫疗法联合应用的意义

Rapisuwon, Suthee; Slingluff, Craig L Jr; Wargo, Jennifer A; Sullivan, Ryan J; Izar, Benjamin; Lin, Jia-Ren; Mauldin, Ileana S; Olson, Walter C; Tran, Christine A; Schwartzman, Gabrielle H; Gibney, Geoffrey T; Al-Refaie, Waddah; Atkins, Michael B

Microbial signals in primary and metastatic brain tumors.

原发性和转移性脑肿瘤中的微生物信号。

Morad Golnaz, Damania Ashish V, Melendez Brenda, Singh Bharat B, Veguilla Fabiana J, Soto Rebecca A, Hoballah Yasmine M, Sahasrabhojane Pranoti V, Wong Matthew C, Ahmed Mona M, Rico Rene N, Lewis Kaitlyn N, Wani Khalida, Shamsutdinova Diana D, Lazcano Segura Rossana N, Ingram Davis R, Goethe Eric A, Day Abderrahman, Flores Ivonne I, McDaniel Lauren K, Chelvanambi Manoj, Johnson Sarah B, Dimitriou Florentia, Gupta Pravesh, Oberai Shivangi, Zal M Anna, Doss Phoebe, Jamal Mohamed A, Hayase Eiko, Wathoo Chetna, Norberg Lisa M, Jenkins Stephanie L, Nass Sara, Gumin Joy, Long Lihong, Yang Jing, Bradley Gina R, Bekal Mahesh Prasad, Dono Antonio G, Pichardo-Rojas Pavel S, Andrewes Samuel W, Ballester Leomar Y, Losh Jillian S, Liang Jiyong, Huo Longfei, Nielsen Douglas C, Parker Kerrigan Brittany C, Brastianos Priscilla K, Fowlkes Natalie Wall, Chang Chia-Chi, Jenq Robert R, Gomez-Manzano Candelaria, Huse Jason T, Davies Michael A, Lazar Alexander J, Bhat Krishna P, Tandon Nitin, Esquenazi Yoshua, Peterson Christine B, Puduvalli Vinay K, Lang Frederick F, Johnston Christopher D, Bullman Susan, Ajami Nadim J, Ferguson Sherise D, Wargo Jennifer A

Author Correction: PPP2R1A mutations portend improved survival after cancer immunotherapy

作者更正:PPP2R1A突变预示着癌症免疫治疗后生存率的提高

Dai, Yibo; Knisely, Anne; Yano, Mitsutake; Dang, Minghao; Hinchcliff, Emily M; Lee, Sanghoon; Welp, Annalyn; Chelvanambi, Manoj; Lastrapes, Matthew; Liu, Heng; Yuan, Zhe; Wang, Chen; Nie, Hao; Jean, Stephanie; Montaner, Luis J; Hou, Jiakai; Patel, Ami; Patel, Shrina; Fellman, Bryan; Yuan, Ying; Sun, Baohua; Pandurengan, Renganayaki Krishna; Cuentas, Edwin Roger Parra; Celestino, Joseph; Liu, Yan; Liu, Jinsong; Hillman, R Tyler; Westin, Shannon N; Sood, Anil K; Soliman, Pamela T; Shafer, Aaron; Meyer, Larissa A; Gershenson, David M; Vining, David; Ganeshan, Dhakshinamoorthy; Lu, Karen; Wargo, Jennifer A; Peng, Weiyi; Zhang, Rugang; Wang, Linghua; Jazaeri, Amir A

Long-Term Survival and Biomarker Analysis Evaluating Neoadjuvant Plus Adjuvant Relatlimab (anti-LAG3) and Nivolumab (anti-PD1) in Patients With Resectable Melanoma

长期生存率和生物标志物分析评估新辅助联合辅助治疗瑞拉利单抗(抗LAG3)和纳武利尤单抗(抗PD-1)在可切除黑色素瘤患者中的疗效

Burton, Elizabeth M; Milton, Denái R; Tetzlaff, Michael T; Wani, Khalida; Ross, Merrick I; Postow, Michael A; Lazcano, Rossana; Glitza, Isabella C; Wong, Michael K; Patel, Sapna P; Diab, Adi; Gershenwald, Jeffrey E; McQuade, Jennifer L; Betof Warner, Allison; Prieto, Victor G; Lee, Jeffrey E; Goepfert, Ryan P; Fisher, Sarah B; Song, Addison; Malke, Jared; Simon, Julie M; Ariyan, Charlotte; Torres-Cabala, Carlos A; Davies, Michael A; Lazar, Alexander; Wargo, Jennifer A; Tawbi, Hussein A; Amaria, Rodabe N

A gut-on-a-chip incorporating human faecal samples and peristalsis predicts responses to immune checkpoint inhibitors for melanoma.

将人类粪便样本和肠蠕动数据整合到芯片上的肠道模型可以预测黑色素瘤对免疫检查点抑制剂的反应

Ballerini Mattia, Galiè Serena, Tyagi Punit, Catozzi Carlotta, Raji Hariam, Nabinejad Amir, Macandog Angeli D G, Cordiale Alessandro, Slivinschi Bianca Ionela, Kugiejko Karol K, Freisa Martina, Occhetta Paola, Wargo Jennifer A, Ferrucci Pier F, Cocorocchio Emilia, Segata Nicola, Vignati Andrea, Morgun Andrey, Deleidi Michela, Manzo Teresa, Rasponi Marco, Nezi Luigi

Mathematical Modeling and Association Analysis Decipher the Impact of the Gut Microbiome on Cancer Immunotherapy

数学建模和关联分析揭示肠道微生物群对癌症免疫疗法的影响

Hadjigeorgiou, Andreas G; Harkos, Constantinos; Mishra, Aditya K; Morad, Golnaz; Johnson, Sarah B; Ajami, Nadim J; Wargo, Jennifer A; Munn, Lance L; Stylianopoulos, Triantafyllos; Jain, Rakesh K

Improved overall survival in an anti-PD-L1 treated cohort of newly diagnosed glioblastoma patients is associated with distinct immune, mutation, and gut microbiome features: a single arm prospective phase I/II trial

在接受抗PD-L1治疗的新诊断胶质母细胞瘤患者队列中,总生存期的改善与独特的免疫、突变和肠道微生物群特征相关:一项单臂前瞻性I/II期试验

Weathers, Shiao-Pei; Li, Xiqi; Zhu, Haifeng; Damania, Ashish V; Knafl, Mark; McKinley, Brian; Lin, Heather; Harrison, Rebecca A; Majd, Nazanin K; O'Brien, Barbara J; Penas-Prado, Marta; Loghin, Monica; Kamiya-Matsuoka, Carlos; Yung, W K Alfred; Solis Soto, Luisa M; Maru, Dipen M; Wistuba, Ignacio; Parra Cuentas, Edwin R; Hernandez, Sharia; Futreal, Andrew; Wargo, Jennifer A; Schulze, Katja; Darbonne, Walter C; Ajami, Nadim J; Woodman, Scott E; de Groot, John F